IVDR and MDR are two distinct European Union regulatory frameworks governing different types of medical devices. The In Vitro Diagnostic Regulation (IVDR) applies to diagnostic tests and laboratory equipment, while the Medical Device Regulation (MDR) covers general medical devices such as implants and surgical instruments. Understanding both regulations is essential for EU medical device compliance, as they have different classification systems, timelines, and conformity assessment requirements that directly affect market access strategies.
What are IVDR and MDR regulations and why do they matter?
IVDR and MDR are comprehensive EU medical device regulations that replaced previous directives to strengthen patient safety and harmonise regulatory requirements across Member States. IVDR governs in vitro diagnostic medical devices, while MDR covers all other medical devices, from bandages to complex implantable systems.
These regulations matter because they establish the legal framework for bringing medical devices to market in the EU. Companies must demonstrate compliance with the applicable requirements before placing products on the market. The regulations introduce stricter clinical evidence requirements, enhanced post-market surveillance obligations, and more rigorous conformity assessment procedures than the previous directives.
Both regulations emphasise patient safety through improved transparency, traceability, and clinical evaluation standards. They also introduce the European database on medical devices (EUDAMED) to improve market oversight. Understanding which regulation applies to your product determines your regulatory pathway, required documentation, and compliance timeline for successful market entry.
What’s the main difference between products covered by IVDR versus MDR?
IVDR covers in vitro diagnostic medical devices used to examine specimens from the human body, while MDR applies to all other medical devices that come into direct or indirect contact with patients. This fundamental distinction determines which regulatory framework applies to your product.
IVDR requirements apply to products such as blood glucose test strips, pregnancy tests, COVID-19 diagnostic kits, laboratory analysers, and genetic testing devices. These products analyse biological samples to provide information about physiological states, diseases, or genetic conditions.
MDR requirements cover medical devices such as surgical instruments, implants, wound dressings, monitoring equipment, software as a medical device, and combination products. Essentially, if a device is not used for diagnostic testing of specimens, it falls under MDR.
The key determining factor is the device’s intended use. Devices that examine specimens derived from the human body to provide diagnostic information fall under IVDR. All other medical devices, regardless of complexity or risk level, are regulated under MDR. Some borderline cases may require careful analysis of the primary intended use to determine the correct regulatory pathway.
How do the classification systems differ between IVDR and MDR?
IVDR uses a four-tier classification system (Class A, B, C, D) based on risk to individual patients and public health, while MDR employs a four-tier system (Class I, IIa, IIb, III) focused primarily on individual patient risk. Both systems determine the level of regulatory oversight required.
Under IVDR, Class A represents the lowest risk (simple self-testing devices), Class B covers moderate individual-risk devices, Class C includes high individual-risk or moderate public health-risk devices, and Class D encompasses the highest-risk devices affecting public health decisions. The classification considers factors such as specimen type, intended user, and the potential impact of incorrect results.
MDR classification ranges from Class I (lowest risk, such as bandages) to Class III (highest risk, such as heart valves). The system evaluates factors including duration of contact, invasiveness, whether the device is active, and the anatomical location of use.
The classification implications differ significantly between the regulations. IVDR generally requires notified body involvement for Classes B, C, and D, while MDR typically requires notified body assessment for Classes IIa, IIb, and III. Higher classifications in both systems demand more extensive clinical evidence, stricter quality management systems, and enhanced post-market surveillance activities.
What are the key compliance timeline differences between IVDR and MDR?
MDR became fully applicable in May 2021, while IVDR implementation was delayed until May 2022 due to the impact of COVID-19 and notified body capacity constraints. Both regulations included transition periods for existing products, but with different deadlines and conditions.
MDR provided a three-year transition period from May 2017 to May 2021, allowing devices with valid MDD or AIMDD certificates to remain on the market until certificate expiry (at the latest until May 2024 for certain devices). The regulation included specific deadlines for EUDAMED registration and unique device identification (UDI) implementation.
IVDR offered a five-year transition period from May 2017 to May 2022, recognising the complexity of diagnostic device regulation. However, the regulation included a staggered approach based on risk classification, with Class D devices required to comply first, followed by Classes C and B, and finally Class A devices.
Currently, new products entering either market must fully comply with the applicable regulation. Existing products operating under transition provisions face upcoming deadlines, particularly for IVDR devices, where many certificates expire in May 2025. Companies must carefully track their specific compliance deadlines and plan submissions accordingly to avoid market disruption.
How do the conformity assessment procedures compare between IVDR and MDR?
Both regulations require conformity assessment procedures proportionate to device risk, but IVDR generally mandates notified body involvement for more device categories than MDR. The procedures verify that devices meet essential requirements before being placed on the market.
Under MDR, Class I devices typically undergo self-declaration of conformity (with some exceptions requiring notified body involvement for sterile or measuring devices). Classes IIa, IIb, and III require varying levels of notified body assessment, from design examination to full quality assurance procedures.
IVDR requires notified body involvement for Classes B, C, and D devices, with only the simplest Class A devices eligible for self-declaration. This means a higher proportion of diagnostic devices require third-party assessment than general medical devices under MDR.
Both regulations emphasise robust quality management systems, clinical evaluation, and post-market surveillance as core conformity assessment elements. However, IVDR places particular emphasis on analytical and clinical performance studies, while MDR focuses more broadly on clinical evaluation and benefit-risk analysis. The documentation requirements are extensive for both, but IVDR includes specific requirements for scientific validity and performance characteristics that reflect the unique nature of diagnostic devices.
Successfully navigating IVDR and MDR requirements requires careful attention to the specific procedures applicable to your device classification. The conformity assessment route determines your timeline, costs, and documentation needs for achieving EU medical device compliance. Understanding these regulatory affairs complexities helps ensure your medical device approval process proceeds smoothly while meeting all essential safety and performance requirements.
How Starodub helps with IVDR and MDR compliance
Starodub provides comprehensive regulatory consulting services to help medical device companies successfully navigate both IVDR and MDR compliance requirements. Our expert team delivers end-to-end support throughout your regulatory journey:
- Regulatory pathway determination: We analyse your device to determine whether IVDR or MDR applies and identify the correct classification
- Gap analysis and compliance planning: We assess your current documentation against regulatory requirements and create detailed compliance roadmaps
- Technical documentation preparation: We help prepare all required technical files, including clinical evaluation reports, risk management files, and post-market surveillance plans
- Notified body liaison: We manage communications with notified bodies and support you through conformity assessment procedures
- EUDAMED registration support: We assist with database registration requirements and UDI implementation
- Ongoing compliance management: We provide post-market surveillance support and help maintain regulatory compliance throughout your product lifecycle
Don’t let complex EU regulations delay your market access. Contact Starodub today to discuss how our proven expertise can streamline your IVDR or MDR compliance journey and accelerate your path to European market success.
Related Articles
- How do you handle regulatory compliance for AI-powered medical devices?
- How does software as medical device (SaMD) regulation work?
- How long does medical device regulatory approval take?
- What is the difference between FDA and EMA regulatory strategies?
- Why is regulatory affairs important for biotech companies?
